We’re experiencing issues for some mobile devices with our ARTG dataset filter function. We apologise for any inconvenience while we work to fix this.
VASOCARDOL CD diltiazem hydrochloride 360 mg capsule bottle, Sanofi-Aventis Australia Pty Ltd, CON-934
Product name
VASOCARDOL CD diltiazem hydrochloride 360 mg capsule bottle
Sponsor name
Sanofi-Aventis Australia Pty Ltd
Consent start
Consent no.
CON-934
Duration
The consent is effective from 27 April 2021 until 31 July 2022.
Standard
Subsection 17(2) of the Therapeutic Goods Order No. 101 - Standard for Tablets, Capsules and Pills (TGO 101)
Non-compliance with standard
The product(s) do not conform to the requirements of subsection 17(2) of the
Therapeutic Goods Order No. 101 - Standard for Tablets, Capsules and Pills (TGO
101), in that the product(s) do not meet the approved dissolution limits after
long term storage.
Conditions imposed
The extent of the non-compliance is only as described in the application dated 9
September 2021 and reiterated in this application dated 6 April 2022.
Import, Supply, &/or Export
Import and supply
Therapeutic product type
Prescription medicines